معرفی
David Christopher Christiani serves as the Elkan Blout Professor of Environmental Genetics at Harvard T.H. Chan School of Public Health and Professor of Medicine at Harvard Medical School and Massachusetts General Hospital. His distinguished career spans molecular epidemiology, environmental health, and genetic susceptibility research, with particular focus on gene-environment interactions in pulmonary and cardiovascular diseases.
Education:
- MD from Tufts University (1976)
- MPH from Harvard School of Public Health (1980)
- MS from Harvard School of Public Health (1981)
Professor Christiani's research program investigates how environmental exposures interact with human genetics to influence disease development and progression. His international work spans Asia, Africa, and North America, examining arsenic exposure effects in Bangladesh and Taiwan, respiratory disease from indoor combustion in Central America, and molecular epidemiology of esophageal cancer in Africa. He has developed biological markers for pollutant-induced diseases including lung, bladder, and skin cancers, and leads the landmark 40-year study of respiratory disease in Shanghai cotton-textile workers.
His extensive publication record reveals consistent focus on lung cancer susceptibility, environmental exposures, and biomarker development. Recent work emphasizes genetic ancestry effects on cancer mutations, environmental toxin impacts on respiratory function, and innovative approaches to cancer risk prediction across diverse populations.
Scientific Recognition:
- Appointed by President Obama to the National Cancer Advisory Board (2012-2019)
Professor Christiani has directed the NCI-funded Boston Lung Cancer Study since 1992 and co-led the Dana-Farber/Harvard Cancer Institute Lung Program for two decades. His research is supported by multiple NIH grants including R01CA285882 (Intratumoral microbiota), U01ES029520 (DNA Repair Capacity), and U01CA209414 (Boston Lung Cancer Survival Cohort). His work bridges laboratory science with population health, developing methods to assess health effects after pollutant exposure while translating findings into disease prevention strategies.
His research teams operate across international boundaries, with collaborators in China, Bangladesh, Taiwan, and Africa. Current projects include molecular epidemiology studies of arsenic exposure in Bangladesh, genetic susceptibility to acute respiratory failure, and biomarker development for lung cancer outcomes. The Boston Lung Cancer Study continues to serve as a critical resource for understanding lung cancer etiology and outcomes in diverse populations.
